首页> 外文期刊>Expert review of anti-infective therapy >Optimizing the diagnostic testing of Clostridium difficile infection
【24h】

Optimizing the diagnostic testing of Clostridium difficile infection

机译:优化艰难梭菌感染的诊断测试

获取原文
获取原文并翻译 | 示例
       

摘要

Introduction: Clostridium difficile infection (CDI) is the leading cause of hospital-acquired diarrhea and is associated with a considerable health and cost burden. However, there is still not a clear consensus on the best laboratory diagnosis approach and a wide variation of testing methods and strategies can be encountered.Areas covered: We aim to review the most practical aspects of CDI diagnosis providing our own view on how to optimize CDI diagnosis.Expert commentary: Laboratory diagnosis in search of C. difficile toxins should be applied to all fecal diarrheic samples reaching the microbiology laboratory in patients > 2years old, with or without classic risk factors for CDI. Detection of toxins either directly in the fecal sample or in the bacteria isolated in culture confirm CDI in the proper clinical setting. Nuclear Acid Assay techniques (NAAT) allow to speed up the process with epidemiological and therapeutic consequences.
机译:简介:艰难梭菌感染(CDI)是医院获得性腹泻的主要原因,并伴有相当大的健康和成本负担。然而,关于最佳实验室诊断方法仍未达成明确共识,并且可能会遇到各种各样的测试方法和策略。涵盖的领域:我们旨在审查CDI诊断的最实际方面,并就如何优化提供自己的见解。 CDI诊断。专家评论:对于2岁以上,有或没有经典CDI危险因素的患者,到达微生物学实验室的所有粪便腹泻样品均应进行实验室诊断以搜寻艰难梭菌毒素。直接在粪便样本中或在培养物中分离出的细菌中检测到毒素,可以在适当的临床环境中确认CDI。核酸分析技术(NAAT)可以加快流行病学和治疗后果的进程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号